BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 26346453)

  • 1. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
    Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
    Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
    Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
    Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
    Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and Cell-Death Pathway in
    Scariot DB; Volpato H; Fernandes NS; Soares EFP; Ueda-Nakamura T; Dias-Filho BP; Din ZU; Rodrigues-Filho E; Rubira AF; Borges O; Sousa MDC; Nakamura CV
    Front Cell Infect Microbiol; 2019; 9():208. PubMed ID: 31259161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
    de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
    Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antileishmanial effects of Physalis angulata root extract on Leishmania infantum.
    Da Silva BJM; Pereira SWG; Rodrigues APD; Do Nascimento JLM; Silva EO
    J Integr Med; 2018 Nov; 16(6):404-410. PubMed ID: 30195443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of imidazole compounds on Leishmania (L.) infantum chagasi: reactive oxygen species induced by econazole.
    Mesquita JT; da Costa-Silva TA; Borborema SE; Tempone AG
    Mol Cell Biochem; 2014 Apr; 389(1-2):293-300. PubMed ID: 24374794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone.
    Mahmoudvand H; Tavakoli R; Sharififar F; Minaie K; Ezatpour B; Jahanbakhsh S; Sharifi I
    Pharm Biol; 2015 Jul; 53(7):1052-7. PubMed ID: 25471014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
    Cunha-Júnior EF; Andrade-Neto VV; Lima ML; da Costa-Silva TA; Galisteo Junior AJ; Abengózar MA; Barbas C; Rivas L; Almeida-Amaral EE; Tempone AG; Torres-Santos EC
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005281. PubMed ID: 28045892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antileishmanial activity of leaf and stem extracts of seven Brazilian plant species.
    de Paula RC; da Silva SM; Faria KF; Frézard F; Moreira CPS; Foubert K; Lopes JCD; Campana PRV; Rocha MP; Silva AF; Silva CG; Pieters L; Almeida VL
    J Ethnopharmacol; 2019 Mar; 232():155-164. PubMed ID: 30580025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
    Pereira IAG; Mendonça DVC; Tavares GSV; Lage DP; Ramos FF; Oliveira-da-Silva JA; Antinarelli LMR; Machado AS; Carvalho LM; Carvalho AMRS; Salustiano IV; Reis TAR; Bandeira RS; Silva AM; Martins VT; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Duarte MC; Menezes-Souza D; Coimbra ES; Leite JPV; Coelho EAF; Gonçalves DU
    Parasite Immunol; 2020 Dec; 42(12):e12784. PubMed ID: 32772379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
    Freitas CS; Oliveira-da-Silva JA; Lage DP; Costa RR; Mendonça DVC; Martins VT; Reis TAR; Antinarelli LMR; Machado AS; Tavares GSV; Ramos FF; Coelho VTS; Brito RCF; Ludolf F; Chávez-Fumagalli MA; Roatt BM; Ramos GS; Munkert J; Ottoni FM; Campana PRV; Humbert MV; Coimbra ES; Braga FC; Pádua RM; Coelho EAF
    Parasitol Res; 2021 Jan; 120(1):321-335. PubMed ID: 33191446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum.
    Mesquita JT; Pinto EG; Taniwaki NN; Galisteo AJ; Tempone AG
    Acta Trop; 2013 Dec; 128(3):666-73. PubMed ID: 24071379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
    Costa RR; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Mendonça DVC; Freitas CS; Lage DP; Martins VT; Antinarelli LMR; Machado AS; Bandeira RS; Ludolf F; Santos TTO; Brito RCF; Humbert MV; Menezes-Souza D; Duarte MC; Chávez-Fumagalli MA; Roatt BM; Coimbra ES; Coelho EAF
    Med Microbiol Immunol; 2021 Jun; 210(2-3):133-147. PubMed ID: 33870453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
    Freitas CS; Santiago SS; Lage DP; Antinarelli LMR; Oliveira FM; Vale DL; Martins VT; Magalhaes LND; Bandeira RS; Ramos FF; Pereira IAG; de Jesus MM; Ludolf F; Tavares GSV; Costa AV; Ferreira RS; Coimbra ES; Teixeira RR; Coelho EAF
    Exp Parasitol; 2023 Aug; 251():108555. PubMed ID: 37247802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.